Global Mechanical Circulator Support Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Percutaneous, IABP, Others, Intracorporeal, VAD, Total Artificial Heart, and Extracorporeal Membrane Oxygenation system.By End-use;
Hospitals, Ambulatory Surgical Centers, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Mechanical Circulator Support Devices Market (USD Million), 2021 - 2031
In the year 2024, the Global Mechanical Circulator Support Devices Market was valued at USD 3,237.26 million. The size of this market is expected to increase to USD 6,071.54 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.4%.
Mechanical circulator support devices, which include ventricular assist devices (VADs) and extracorporeal membrane oxygenation (ECMO) machines, play a critical role in supporting patients with severe heart or lung failure. One of the primary drivers of market growth is the rising prevalence of cardiovascular and respiratory diseases worldwide. With an aging population and lifestyle factors such as poor diet and lack of exercise contributing to the increase in these conditions, the demand for mechanical circulator support devices is poised to surge. Advancements in technology have led to the development of more efficient and minimally invasive devices, expanding the potential patient pool for these life-saving interventions. Increasing awareness among healthcare professionals and patients about the benefits of mechanical circulator support devices is fueling market growth, as these devices offer a viable treatment option for individuals who are not candidates for heart or lung transplants.
Despite the promising growth prospects, the market for mechanical circulator support devices faces certain challenges. One of the major hurdles is the high cost associated with these devices and their implantation procedures, which limits their accessibility, especially in developing regions. The complex nature of these devices requires specialized training for healthcare professionals, leading to concerns regarding the availability of skilled personnel to operate and manage them effectively. Regulatory hurdles and reimbursement issues in some regions pose obstacles to market expansion. With ongoing research and development efforts aimed at improving device efficacy, safety, and affordability, coupled with initiatives to enhance healthcare infrastructure and access, the global mechanical circulator support devices market is expected to witness continued growth in the coming years.
Global Mechanical Circulator Support Devices Market Recent Developments
-
In May 2024, BrioHealth Solutions, Inc., a medical technology company, announced it received FDA Investigational Device Exemption (IDE) approval to enroll participants in its INNOVATE trial, which evaluated the effectiveness and safety of the BrioVAD System for severe left ventricular heart failure.
-
In December 2023, CARMAT, the designer and developer of the world's most advanced total artificial heart for patients with advanced biventricular heart failure, announced the opening of its second production facility, BDA2, located in Bois-d'Arcy, France.
Segment Analysis
The global mechanical circulatory support devices market is experiencing significant growth propelled by advancements in medical technology and an increasing prevalence of cardiovascular diseases worldwide. Across various product categories such as percutaneous devices, intra-aortic balloon pumps (IABP), intracorporeal ventricular assist devices (VADs), total artificial hearts, and extracorporeal membrane oxygenation (ECMO) systems, the market is witnessing a surge in demand. Percutaneous devices, offering minimally invasive options for circulatory support, are particularly gaining traction due to their ability to reduce complications and improve patient outcomes. VADs and total artificial hearts are catering to patients with advanced heart failure, offering them a lifeline while awaiting heart transplantation or as a destination therapy. The versatility of ECMO systems in providing both cardiac and respiratory support further adds to the market's expansion, especially in critical care settings.
End-use factors also play a crucial role in shaping the market landscape, with hospitals emerging as the primary consumers of mechanical circulatory support devices. The increasing prevalence of heart failure cases treated in hospital settings, coupled with the availability of skilled healthcare professionals and advanced infrastructure, drives the adoption of these devices. Ambulatory surgical centers are also witnessing a rising demand for mechanical circulatory support devices, particularly for patients requiring short-term circulatory support or those undergoing procedures such as high-risk cardiac surgeries. The market is seeing growth opportunities in other healthcare settings, including specialty clinics and home care settings, as technological advancements enable the delivery of mechanical circulatory support outside traditional hospital environments.
Global Mechanical Circulator Support Devices Segment Analysis
In this report, the Global Mechanical Circulator Support Devices Market has been segmented by Product, End-use and Geography.
Global Mechanical Circulator Support Devices Market, By Product
The Global Mechanical Circulator Support Devices Market has been segmented by Product into Percutaneous, IABP, Others, Intracorporeal, VAD, Total Artificial Heart and Extracorporeal Membrane Oxygenation system.
Percutaneous devices represent a significant category within this market, offering minimally invasive solutions for circulatory support. These devices, such as percutaneous ventricular assist devices (PVADs), are designed to provide temporary support to failing hearts, often during high-risk procedures or while awaiting heart transplant. They offer advantages like reduced recovery times and lower risks of complications compared to traditional open-heart surgeries, thus driving their demand and adoption in clinical settings worldwide.
In addition to percutaneous options, the market encompasses a range of other mechanical circulator support devices. Intra-aortic balloon pumps (IABPs) stand out as a widely used method for augmenting coronary blood flow and cardiac output, particularly in cases of acute myocardial infarction or cardiogenic shock. Intracorporeal ventricular assist devices (VADs), total artificial hearts, and extracorporeal membrane oxygenation (ECMO) systems provide more comprehensive circulatory support, serving patients with severe heart failure or those undergoing complex cardiac surgeries. These advanced devices represent cutting-edge innovations in medical technology, offering longer-term solutions for patients with advanced heart disease.
Global Mechanical Circulator Support Devices Market, By End-use
The Global Mechanical Circulator Support Devices Market has been segmented by End-use into Hospitals, Ambulatory Surgical Centers and Others.
One crucial segment comprises hospitals, which serve as the primary centers for medical intervention and critical care. Within hospital settings, mechanical circulator support devices find widespread use across various departments, including intensive care units (ICUs), cardiac care units (CCUs), and operating rooms. These devices play a pivotal role in stabilizing patients with severe cardiac or respiratory failure, providing temporary support until their conditions improve or until a more definitive treatment such as transplantation becomes available. Hospitals, equipped with advanced medical infrastructure and skilled healthcare professionals, represent key hubs for the deployment and management of mechanical circulator support devices, ensuring timely intervention and optimal patient outcomes.
The market segmentation extends to encompass ambulatory surgical centers, which offer specialized surgical procedures on an outpatient basis. These centers provide a crucial alternative to traditional hospital settings, offering convenience and efficiency for patients requiring surgical interventions that do not necessitate prolonged hospital stays. In such settings, mechanical circulator support devices may be utilized during complex surgical procedures where there's a risk of hemodynamic instability or compromised cardiac function. Ambulatory surgical centers leverage these devices to enhance patient safety and facilitate smoother post-operative recovery, underscoring their importance within the broader landscape of medical care delivery.
Global Mechanical Circulator Support Devices Market, By Geography
In this report, the Global Mechanical Circulator Support Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Mechanical Circulator Support Devices Market Share (%), by Geographical Region, 2024
In North America, technological advancements coupled with robust healthcare infrastructure drive market growth. The region witnesses significant adoption of mechanical circulator support devices, attributed to the high prevalence of cardiovascular diseases and organ failures. In Europe, stringent regulatory frameworks ensure the safety and efficacy of mechanical circulator support devices, fostering market growth. The region's aging population contributes to the rising incidence of cardiac ailments, propelling demand for these devices. Strategic initiatives by market players to introduce innovative products and expand their geographical footprint reinforce market development. In Asia Pacific, improving healthcare infrastructure, growing disposable incomes, and increasing awareness about advanced treatment options drive market growth. Countries like China and India present lucrative opportunities for market players due to the large patient pool and favorable government initiatives.
In the Middle East and Africa, a burgeoning prevalence of cardiovascular diseases and a growing demand for advanced medical technologies fuel market growth. Limited access to healthcare facilities and economic constraints pose challenges to market penetration. Increasing investments in healthcare infrastructure and rising healthcare expenditure are expected to drive market growth in the region. In Latin America, improving healthcare access, rising disposable incomes, and a growing geriatric population are key factors driving market expansion. Collaborations between healthcare organizations and government initiatives to improve healthcare services further stimulate market growth. Despite these opportunities, market growth may be hindered by economic instability and inadequate reimbursement policies in certain countries.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Mechanical Circulator Support Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Growing heart disease cases
- Better device technology
- Aging population's heart issues
-
Increased use in organ transplants - Mechanical circulator support devices play a crucial role in maintaining organ viability during the transplantation process, especially for organs like the heart and lungs, which are sensitive to ischemic damage. By providing temporary circulatory support, these devices ensure adequate blood flow to the transplanted organ, reducing the risk of ischemia-related complications and improving the success rate of transplant surgeries.
Mechanical circulator support devices allow for better organ preservation during transportation, extending the window of opportunity for organ transplantation and enabling more efficient allocation of donor organs. As transplant procedures become more common and organ shortages persist, the increased use of circulator support devices represents a promising solution to enhance transplant outcomes and save more lives.
Restraints
- Ethical concerns
- Limited awareness
-
Maintenance challenges - While mechanical circulator support devices offer significant benefits in terms of patient care and outcomes, they also present maintenance challenges for healthcare facilities and providers. These devices require regular monitoring, calibration, and maintenance to ensure optimal performance and patient safety. Maintenance tasks may include cleaning, sterilization, and periodic inspection of components to detect any signs of wear or malfunction.
Healthcare professionals need to undergo specialized training to effectively manage and troubleshoot these devices. Limited availability of skilled personnel and resources, as well as stringent regulatory requirements, can pose challenges in maintaining a consistent standard of care across different healthcare settings. Addressing maintenance challenges requires a comprehensive approach involving training programs, streamlined maintenance protocols, and investment in infrastructure and resources to support device management.
Opportunities
- Remote monitoring demand rises
- Home healthcare expands
- Telemedicine and digital health surge
-
Distribution network expansion in underserved areas - Many regions, particularly in rural and remote areas, lack adequate healthcare infrastructure and resources, leading to limited access to specialized medical treatments and interventions. By expanding the distribution network, medical device manufacturers and distributors can ensure that mechanical circulator support devices reach healthcare facilities and providers in these underserved areas.
This requires strategic partnerships, logistical planning, and investment in transportation and storage infrastructure to overcome geographical barriers and reach remote communities. Tailored pricing strategies and financial assistance programs may be implemented to make these devices more affordable and accessible to patients in low-resource settings. By expanding the distribution network to underserved areas, stakeholders can contribute to improving healthcare equity and reducing disparities in access to life-saving medical interventions.
Competitive Landscape Analysis
Key players in Global Mechanical Circulator Support Devices Market include
- Abbott Laboratories
- Boston Scientific Corporation
- Cardiobridge GmbH
- Getinge AB
- LivaNova PLC
- Medtronic plc
- Koninklijke Philips N.V.
- Terumo Corporation
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By End-use
- Market Snapshot, By Region
- Global Mechanical Circulator Support Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Growing heart disease cases
- Better device technology
- Aging population's heart issues
- Increased use in organ transplants
- Restraints
- Ethical concerns
- Limited awareness
- Maintenance challenges
- Opportunities
- Remote monitoring demand rises
- Home healthcare expands
- Telemedicine and digital health surge
- Distribution network expansion in underserved areas
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Mechanical Circulator Support Devices Market, By Product, 2021 - 2031 (USD Million)
- Percutaneous
- IABP
- Intracorporeal
- VAD
- Total Artificial Heart
- Extracorporeal Membrane Oxygenation system
- Others
- Global Mechanical Circulator Support Devices Market, By End-use, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Others
- Global Mechanical Circulator Support Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Mechanical Circulator Support Devices Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape Analysis
- Company Profiles
- Abbott Laboratories
- Boston Scientific Corporation
- Cardiobridge GmbH
- Getinge AB
- LivaNova PLC
- Medtronic plc
- Koninklijke Philips N.V.
- Terumo Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market